GeneDx Holdings Corp.
WGS · XNASCIK 1818331fmd_13NEYDC4P54JKEFE69HJDPST4AServices · Services-Health ServicesTemplate: Standard
Coverage: Jan 01, 2019 to Sep 30, 2026, 28 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Total revenues | 196 | 179 | 212 | 235 | 203 | 305 | 428 |
| Cost of revenue | 113 | 175 | 229 | 261 | 113 | 111 | 129 |
| Net interest income | – | – | – | (1) | 1 | – | – |
| Gross profit | 83 | 4 | (17) | (27) | 90 | 194 | 298 |
| Research and development | 35 | 73 | 105 | 86 | 58 | 46 | 72 |
| Selling, general and administrative | 69 | 164 | 319 | 338 | 200 | 172 | 239 |
| Operating income | (30) | (242) | (446) | (668) | (181) | (23) | (13) |
| Interest expense | 1 | 2 | 3 | 3 | – | – | – |
| Interest and investment income | 1 | 1 | 0 | 3 | – | – | – |
| Other non-operating income (expense) | 1 | 1 | 201 | 70 | 4 | (29) | (8) |
| Income before taxes | (30) | (241) | (245) | (598) | (177) | (53) | (21) |
| Income tax expense | 0 | 0 | 0 | (49) | (1) | (0) | (0) |
| Net income from continuing operations | (30) | (241) | (245) | (549) | (176) | (52) | (21) |
| Net income | (30) | (241) | (245) | (549) | (176) | (52) | (21) |
| Net income to common shareholders | (33) | (241) | (245) | – | – | – | – |